Paul A. Laviolette is COO at BOSTON SCIENTIFIC CORP (BSX). They have made 2 open-market trades across 2 companies since 2007, most recently 2026-05-11.
CIK 0001191249
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $295K since 2026, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BSX | 69,422 | $3.1M |
| EW | 17,552 | $1.5M |
| PLSE | 15,000 | $665K |
| THOR | 23,477 | $597K |
| TRXC | 31,401 | $127K |
| ASXC | 13,846 | $5K |
| CPTS | 35,180 | — |
| Total | $6.0M |
Shares reported on the most recent Form 4, priced at the 2026-05-11 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PLSE | BUY | 2026-05-11 | 2026-05-11 | $19.69 | $295K | +19.2% | +16.5% | +93.3% |
| THOR | SELL · 10b5-1 | 2015-05-15 | 2015-05-18 | $44.70 | $253K | -2.7% | -18.1% | -18.1% |
| THOR | SELL · 10b5-1 | 2014-05-15 | 2014-05-15 | $31.23 | $188K | -2.7% | -18.1% | -18.1% |
| THOR | SELL · 10b5-1 | 2014-01-02 | 2014-01-07 | $36.17 | $109K | -2.7% | -18.1% | -18.1% |
| BSX | SELL | 2007-10-31 | 2007-11-02 | $13.93 | $780K | -3.4% | -0.9% | -0.9% |
| BSX | SELL · 10b5-1 | 2007-04-26 | 2007-04-27 | $15.86 | $5.4M | -3.4% | -0.9% | -0.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.